Second Genome Inc.
Personalizing medicine by better understanding bacteria
This article was originally published in Start Up
Second Genome Inc. intends to leverage new understandings arising from research into the human microbiome about how microorganisms influence human disease and health. The start-up anticipates that its microbiome discovery platform will expose many possibilities for diagnosis and treatment of disease not previously connected with bacteria. Initially the start-up is intent on establishing that its methods can classify patients with irritable bowel syndrome and guide their treatment.